Access cutting-edge retinoblastoma treatment through this clinical trial at a research site in Palo Alto. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Palo Alto location
Access retinoblastoma specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related retinoblastoma treatment provided free
Check if you qualify for this retinoblastoma clinical trial in Palo Alto, CA
No-Cost Study Care
Local to Palo Alto
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This phase II trial tests the safety and side effects of adding melphalan (by injecting it into the eye) to standard chemotherapy in early treatment of patients with retinoblastoma (RB). RB is a type of cancer that forms in the tissues of the retina (the light-sensitive layers of nerve tissue at the back of the eye). It may be hereditary or nonhereditary (sporadic). RB is considered harder to treat (higher risk) when there are vitreous seeds present. Vitreous seeds are RB tumors in the jelly-lik
Sponsor: Children's Oncology Group
Yes, this clinical trial (NCT05504291) has an active research site in Palo Alto, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for retinoblastoma treatment options in Palo Alto, CA, this clinical trial (NCT05504291) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Palo Alto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced retinoblastoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all retinoblastoma clinical trials near you to find additional studies recruiting in your area.
See all essential tremor clinical trials recruiting in Palo Alto — not just this study.
Browse Essential Tremor Trials in Palo Alto →